SAGE sagerx.com Net Financial Result

Official company branding of Sage Therapeutics Inc. (SAGE)

The loyalty of the scientific staff provides a stable foundation, yet the long-term success of Sage Therapeutics, Inc. (SAGE) relies on the commercialization of Zurzuvae and the fight against depression. The GURU.Markets interface displays this chart, where the company's financial profit is recorded by a metric value of -0.30. This trend is confirmed by growing demand for innovative neuropreparations in a segment that has not yet reached saturation.

Sage Therapeutics, Inc (SAGE) Net Profit: for the period 07/04/2022 - 08/16/2025

Comprehensive metric breakdowns and analytics for Sage Therapeutics (SAGE)

- stock value and consensus price forecast:
Market Price Sage Therapeutics Inc|SAGE - Price Target Chart
- market capitalization data:
Market Capitalization Sage Therapeutics Inc|SAGE - Enterprise Value
- shareholders' equity book value data:
Book Value per Share Sage Therapeutics|SAGE - Book Capitalization|Market Value to Equity Ratio sagerx.com|SAGE - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Sage Therapeutics, Inc.|SAGE - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Sage Therapeutics Inc.|SAGE - Company Total Debt|Debt to Book Capital Sage Therapeutics Inc|SAGE - Company Long-Term Debts|Company Short-Term Loans and Borrowings Sage Therapeutics|Immediate Liquidity sagerx.com
- earnings and market multiples details:
SAGE - Company Net Income
Summary company analysis:Sage Therapeutics Inc - SAGE
Signature product of Sage Therapeutics Inc.

To minimize risks during long-term investing, it is critical to analyze the net profit dynamics of a company, which filters out volatility through daily market equilibrium points and reveals the real drivers of value. For Sage Therapeutics, Inc. (SAGE), this indicator reflects the effectiveness of Barry Green's strategy to balance colossal R&D costs and the commercialization of antidepressants, confirming the fundamental resilience of the business.

Direct competitors

Company Net Income Biogen Idec (BIIB)|Company Net Income Neurocrine Biosciences|regencellbioscience.com (RGC) - Net Financial Result|Net Profit AXSM|Net Profit ACADIA Pharma (ACAD)|Net Profit XENE (Xenon Pharmaceuticals Inc)|Annual Net Income Viking Therapeutics Corp|Supernus Pharmaceuticals - Net Profit|Company Net Income catalystpharma.com|DNLI (Denali Therapeutics Inc.) - Net Income|Harmony Biosciences Inc - Final Profit|Net Income BHVN|AMLX (Amylyx Corp) - Profit After Payment of Taxes|Net Profit TRVI|PRAX (praxismedicines.com) - Final Profit|Net Profit AVXL (Anavex Life Sciences Corp.)|CeriBell Inc (CBLL) - Company Net Income|PRTA - Company Net Income|Final Profit ALEC (Alector, Inc.)|ANNX: Net Profit|Omeros (OMER) - Net Profit|Company Net Income Neurogene|AC Immune S.A. - Profit After Tax|Net Profit VYGR|NMRA - Company Net Income|Scilex Holding Company - Net Income|Net Profit tevogen.com TVGN|ACOG: Net Income|cogrx.com - Profit After Payment of Taxes|IKT: Net Profit|SAVA - Net Financial Result|ASRT (Assertio Holdings) - Net Profit|Net Income Coya (COYA)|Company Net Income Vistagen Therapeutics (VTGN)|Net Financial Result ovidrx.com|Acumen Pharma - Net Income|Final Profit CRVO|Alterity Therapeutics Ltd - Net Profit|Net Financial Result Clene Inc. CLNN|pepgen.com (PEPG) - Company Net Income|Company Profit JUNS|RLMD (Relmada) - Net Profit|Net Income Annovis Bio Corporation (ANVS)|Net Income GRCE (Grace Therapeutics, Inc.)|Net Financial Result fireflyneuro.com|Company Net Income Klotho Neurosciences KLTO|Net Financial Result NeuroSense Therapeutics Ltd (NRSN)|Reviva Pharmaceuticals Holdings - Net Profit|MTVA - Net Profit|NRXS: Net Profit|Annual Net Income Helius Medical Technologies HSDT|PASG (Passage Bio Inc.) - Net Profit|Company Net Income Neuphoria NEUP|Company Net Income Minerva Neurosciences Corp (NERV)|Athira Pharma Corp - Company Profit|Net Profit ADXN (Addex Therapeutics)|Alzamend Neuro Inc. (ALZN) - Company Net Income|CYCN: Net Income|PTIX - Net Profit|pasitheaclinics.com (KTTA) - Company Net Income|Cortigent - Final Profit|Company Net Income Avenue Therapeutics|Company Net Income brainstorm-cell.com BCLI|Company Net Income Cara Therapeutics (CARA)|Net Financial Result Chromocell Therapeutics Corp|Net Profit ELYM (Eliem Therapeutics Inc.)|Net Profit Intra-Cellular Therapies Inc. ITCI|Longboard Pharmaceuticals - Net Profit|Annual Net Income marinuspharma.com (MRNS)|NKGN: Net Profit|Company Net Income NeuroBo Pharmaceuticals Inc (NRBO)|Net Income SNPX|TRVN: Final Profit|Net Income VIGL (Vigil Neuroscience)|Profit After Payment of Taxes WENA|Net Profit CERE (Cerevel Therapeutics, Inc.)